NAD+ bioavailability decreases as we age and during viral infections, in part due to upregulation of NAD+ consuming enzymes, such as poly(ADP-ribose) polymerase 1 (PARP1) [122], which interacts with NF-kB signaling, precipitating further chronic inflammation and oxidative stress [91]. Here, NFKB1 is linked to viral infectious disease.